Search Results

Eisai Co.,Ltd.: EISAI INITIATES ROLLING SUBMISSION TO THE U.S. FDA FOR BLA OF LECANEMAB FOR EARLY ALZHEIMER'S DISEASE UNDER THE ACCELERATED APPROVAL PATHWAY.

• Source: Plus Company Updates. 2021.

Record details

Epilepsy Update.

Subjects: *PHARMACEUTICAL industry; DRUG approval; LENNOX-Gastaut syndromeUNITED StatesEISAI Co. Ltd. EISAI Co. Ltd. EISAI Co. Ltd. 189246791 ; SEPRACOR Inc. SEPRACOR Inc. SEPRACOR Inc. SEPR; UNITED States. Food & Drug Administration

• Source: PharmaWatch: CNS. Jun2010, Vol. 9 Issue 6, p11-12. 2p.

Record details

Eisai and TSD Japan sign licensing and joint development agreement.

Subjects: *BUSINESS partnerships; *LICENSE agreements; DRUG developmentJAPANEISAI Co. Ltd. EISAI Co. Ltd. EISAI Co. Ltd. 189246791 ; TSD Japan Inc.

• Source: PharmaWatch: Cancer. Dec2009, Vol. 8 Issue 12, p15-16. 2p.

Record details

Eisai: novel Fycompa expands treatment options for refractory epilepsy in US.

Subjects: DRUG approval; SPASM treatmentUNITED States; UNITED Kingdom; EUROPEEISAI Co. Ltd. EISAI Co. Ltd. EISAI Co. Ltd. 189246791 ; UNITED States. Food & Drug Administration

• Source: PharmaWatch: CNS. Dec2012, Vol. 11 Issue 12, p4-5. 2p.

Record details

Decitabine/Cedazuridine: First Approval.

• Authors : Dhillon S; Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand. .

Subjects: Decitabine/Decitabine/Decitabine/*therapeutic use ; Drug Approval/Drug Approval/Drug Approval/*history ; Drug Development/Drug Development/Drug Development/*history

• Source: Drugs [Drugs] 2020 Sep; Vol. 80 (13), pp. 1373-1378.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 7600076 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Epilepsy Update.

Subjects: DRUG approval; ANTICONVULSANTSEISAI Co. Ltd. EISAI Co. Ltd. EISAI Co. Ltd. 189246791 ; EUROPEAN Medicines Agency ; UNITED States. Food & Drug Administration

• Source: PharmaWatch: CNS. Sep2011, Vol. 10 Issue 9, p12-12. 2/3p.

Record details

Eisai announces EMA acceptance for review of epilepsy drug.

Subjects: TREATMENT of epilepsy; DRUG approvalEUROPE; UNITED StatesEISAI Co. Ltd. EISAI Co. Ltd. EISAI Co. Ltd. 189246791 ; EUROPEAN Medicines Agency

• Source: PharmaWatch: CNS. Aug2011, Vol. 10 Issue 8, p8-8. 1/2p.

Record details

Epilepsy Update.

Subjects: TREATMENT of epilepsy; DRUG approvalUNITED StatesNOBELPHARMA Co. Ltd. ; EISAI Co. Ltd. EISAI Co. Ltd. EISAI Co. Ltd. 189246791 ; UCB SA UCB SA UCB SA 043546522

• Source: PharmaWatch: CNS. Mar2012, Vol. 11 Issue 3, p7-8. 2p.

Record details

COMPANY SPOTLIGHT - Eisai Co.

Subjects: *SWOT analysis; *PHARMACEUTICAL industry; ALZHEIMER'S disease treatmentJAPANEISAI Co. Ltd. EISAI Co. Ltd. EISAI Co. Ltd. 189246791

• Source: PharmaWatch: CNS. Sep2009, Vol. 8 Issue 9, p27-31. 5p.

Record details

I&I News Round-Up.

Subjects: AUTOIMMUNE disease treatment; CLINICAL trials; DRUG approvalUNITED StatesEISAI Co. Ltd. EISAI Co. Ltd. EISAI Co. Ltd. 189246791 ; PROVECTUS Biopharmaceuticals Inc. ; GRACEWAY Pharmaceuticals LLC

• Source: PharmaWatch: Monthly Review. May2010, Vol. 9 Issue 5, p16-17. 2p.

Record details